BioSpace News Archive

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that the U.S. Food and Drug Administration has set the Prescription Drug User Fee Act date for the New Drug Application for Maxigesic® IV on 30 June 2022.

Rapid sterility tests have absolute sensitivity and specificity for bacterial detection and can identify viable microbes within the scope of microbiological development. These ensure testing in rapid and accurate manner.

The patient registry software market is anticipated to experience noteworthy growth avenues in the upcoming years.

Transparency Market Research has published a new report titled, ‘Extracorporeal Membrane Oxygenation Machine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to Transparency Market Research, the global endometrial ablation market is foreseen to exhibit a steady CAGR of 5.50% within the forecast period from 2016 to 2024.

Biosimilars can be defined as a biologic medical product, which is considered to be similar to already approved biologic.

Valbiotis, a Research and Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the selection of TOTUM•070’s positive preclinical results in hypercholesterolemia by the annual meeting of the American Heart Association, the leading American learned society in the cardiovascular field.

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that Company representatives will be attending MEDICA 2021 to showcase ColoAlert, its highly efficacious and easy-to-use diagnostic test for colorectal cancer.

AcelRx Pharmaceuticals, Inc. announced the execution of a definitive merger agreement to acquire Lowell Therapeutics, Inc., a privately held company, and reported its third quarter 2021 financial results.

DarioHealth Corp. today announced that the Company appointed Jerrod Helms to the newly created role of Chief Commercial Officer